JAK1 and neoplasm: Delicaflavone, a biflavonoid compound purified from S. doederleinii, selectively inhibited the JAK1-STAT6 signaling pathway in M2-polarized tumor-associated macrophages and myeloid-derived suppressor cells, effectively reprogramming immunosuppressive tumor microenvironments to restore anti-tumor immunity [32].